A detailed history of Jpmorgan Chase & CO transactions in Zim Vie Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 183,419 shares of ZIMV stock, worth $2.54 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
183,419
Previous 110,024 66.71%
Holding current value
$2.54 Million
Previous $2.01 Million 44.99%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$15.43 - $21.95 $1.13 Million - $1.61 Million
73,395 Added 66.71%
183,419 $2.91 Million
Q2 2024

Aug 12, 2024

BUY
$14.79 - $18.47 $913,637 - $1.14 Million
61,774 Added 128.03%
110,024 $2.01 Million
Q1 2024

May 10, 2024

BUY
$15.92 - $20.69 $479,972 - $623,782
30,149 Added 166.56%
48,250 $795,000
Q4 2023

Feb 12, 2024

SELL
$6.73 - $18.28 $3,001 - $8,152
-446 Reduced 2.4%
18,101 $321,000
Q3 2023

Nov 14, 2023

SELL
$9.2 - $14.12 $23,487 - $36,048
-2,553 Reduced 12.1%
18,547 $174,000
Q2 2023

Aug 11, 2023

SELL
$7.21 - $12.14 $218,174 - $367,356
-30,260 Reduced 58.92%
21,100 $236,000
Q1 2023

May 18, 2023

BUY
$5.31 - $11.98 $84,646 - $190,973
15,941 Added 45.01%
51,360 $371,000
Q1 2023

May 11, 2023

BUY
$5.31 - $11.98 $82,395 - $185,893
15,517 Added 77.97%
35,419 $256,000
Q4 2022

Feb 13, 2023

SELL
$6.86 - $10.65 $214,916 - $333,653
-31,329 Reduced 61.15%
19,902 $186,000
Q3 2022

Nov 14, 2022

SELL
$9.37 - $19.88 $164,415 - $348,834
-17,547 Reduced 25.51%
51,231 $504,000
Q2 2022

Aug 11, 2022

SELL
$16.01 - $27.99 $420,294 - $734,793
-26,252 Reduced 27.62%
68,778 $1.1 Million
Q1 2022

May 11, 2022

BUY
$22.47 - $45.75 $2.14 Million - $4.35 Million
95,030 New
95,030 $2.17 Million

Others Institutions Holding ZIMV

About ZimVie Inc.


  • Ticker ZIMV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 26,084,000
  • Market Cap $361M
  • Description
  • ZimVie Inc., a medical technology company, develops, manufactures, and delivers a portfolio of products and solutions designed to treat a range of spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; bo...
More about ZIMV
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.